NCT04412200View on ClinicalTrials.gov

Efficacy of Hyperbaric Oxygen Therapy (HBOT) in New-onset Type-1 Diabetes Mellitus

NARecruitingINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

June 1, 2020

Primary Completion Date

November 30, 2024

Study Completion Date

May 31, 2026

Conditions
T1DM
Interventions
DEVICE

Hyperbaric oxygen chamber (HBOC)

HBOC group will receive 100% oxygen at 2 ATA for 90 min with 5 min air breaks every 20 min at each session. Intensive management period includes 60 daily sessions, 5 days per week within 12 weeks,

Trial Locations (2)

70300

RECRUITING

Asaf harofe medical center, Tzrifin

RECRUITING

Assaf Haroffeh Medical center, Zrifin

All Listed Sponsors
lead

Assaf-Harofeh Medical Center

OTHER_GOV